Oligoastrocytoma
What's New
Last Posted: May 22, 2023
- Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis.
Kwanghoon Lee, et al. Scientific reports 2023 0 (1) 6761 - Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases.
Zetterling Maria, et al. PloS one 2017 0 (11) e0188419 - High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients.
Wu Zijun, et al. Frontiers in cell and developmental biology 2021 0 679684 - Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion.
Zhu Jin, et al. World neurosurgery 2021 0 e1174-e1179 - Allergy may confer better survival on patients with gliomas.
Lehrer Steven, et al. Clinical neurology and neurosurgery 2019 0 63-67 - Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki Keisuke, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2002 0 (1) 196-201 - Subtyping and grading of lower-grade gliomas using integrated feature selection and support vector machine.
Munquad Sana et al. Briefings in functional genomics 2022 - Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma.
Zhu Jin, et al. PeerJ 2019 0 e7414 - von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.
Lehrer Steven, et al. Brain tumor research and treatment 2019 4 (1) 33-38 - Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
Rajmohan K S, et al. Journal of clinical pathology 2016 1
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 18, 2024
- Content source: